IRIS
GUIDO, Maurizio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.759
NA - Nord America 2.280
SA - Sud America 1.465
EU - Europa 788
Continente sconosciuto - Info sul continente non disponibili 193
AF - Africa 180
OC - Oceania 3
Totale 9.668
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.078
SG - Singapore 2.011
BR - Brasile 1.047
VN - Vietnam 782
CN - Cina 728
HK - Hong Kong 336
BD - Bangladesh 305
IT - Italia 273
FR - Francia 173
KR - Corea 168
AR - Argentina 152
IQ - Iraq 73
MX - Messico 67
EC - Ecuador 65
DE - Germania 63
CA - Canada 59
CO - Colombia 57
IN - India 57
RU - Federazione Russa 56
GB - Regno Unito 48
ZA - Sudafrica 48
NL - Olanda 42
ID - Indonesia 39
CL - Cile 36
PK - Pakistan 35
VE - Venezuela 29
TR - Turchia 27
MA - Marocco 26
TN - Tunisia 25
PY - Paraguay 23
UZ - Uzbekistan 23
FI - Finlandia 22
UY - Uruguay 22
EG - Egitto 19
MY - Malesia 19
SA - Arabia Saudita 19
UA - Ucraina 19
PE - Perù 18
ES - Italia 16
DZ - Algeria 15
PH - Filippine 14
BO - Bolivia 13
KZ - Kazakistan 13
NP - Nepal 12
AG - Antigua e Barbuda 11
JO - Giordania 11
KE - Kenya 11
AZ - Azerbaigian 10
CR - Costa Rica 10
ET - Etiopia 10
PL - Polonia 10
JM - Giamaica 9
JP - Giappone 9
PA - Panama 9
SE - Svezia 9
DO - Repubblica Dominicana 8
BH - Bahrain 7
AL - Albania 6
AT - Austria 6
KW - Kuwait 6
LB - Libano 6
AE - Emirati Arabi Uniti 5
GT - Guatemala 5
IR - Iran 5
KG - Kirghizistan 5
NI - Nicaragua 5
OM - Oman 5
QA - Qatar 5
SN - Senegal 5
BG - Bulgaria 4
BY - Bielorussia 4
CI - Costa d'Avorio 4
CY - Cipro 4
HN - Honduras 4
IL - Israele 4
LT - Lituania 4
PR - Porto Rico 4
PS - Palestinian Territory 4
RS - Serbia 4
SV - El Salvador 4
AU - Australia 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
IE - Irlanda 3
LK - Sri Lanka 3
LY - Libia 3
MD - Moldavia 3
TT - Trinidad e Tobago 3
AO - Angola 2
BW - Botswana 2
EE - Estonia 2
GA - Gabon 2
GR - Grecia 2
HU - Ungheria 2
KH - Cambogia 2
LV - Lettonia 2
SR - Suriname 2
SY - Repubblica araba siriana 2
TG - Togo 2
TJ - Tagikistan 2
Totale 9.452
Salva come PNG Salva come JPEG
Città #
Singapore 746
San Jose 493
Council Bluffs 465
Hong Kong 332
Ashburn 317
Ho Chi Minh City 297
Hefei 272
Beijing 188
Seoul 163
Hanoi 157
Lauterbourg 154
Dallas 134
São Paulo 93
New York 71
Santa Clara 67
Da Nang 41
Los Angeles 40
Amsterdam 37
Rio de Janeiro 35
Munich 28
Haiphong 27
Mexico City 26
Baghdad 25
Tianjin 24
Biên Hòa 23
Phoenix 23
Rome 23
Brasília 22
Rende 22
Dhaka 21
Hải Dương 20
Tashkent 20
Milan 19
Omaha 19
Toronto 19
Guayaquil 18
Johannesburg 18
Fortaleza 17
Naples 17
Quito 17
Brooklyn 16
Curitiba 16
Helsinki 16
Montevideo 16
Belo Horizonte 15
Campinas 15
Porto Alegre 15
Chicago 14
Columbus 14
San Francisco 14
Bogotá 13
Cape Town 13
Medellín 13
Frankfurt am Main 11
Orem 11
Santiago 11
Seattle 11
St John's 11
Amman 10
Buffalo 10
Guangzhou 10
Istanbul 10
Kuala Lumpur 10
Lima 10
Tunis 10
Addis Ababa 9
Baku 9
Boston 9
Buenos Aires 9
Can Tho 9
Joinville 9
London 9
Montreal 9
Nairobi 9
Nova Iguaçu 9
Salvador 9
Stockholm 9
Bologna 8
Cairo 8
Carapicuíba 8
Guarulhos 8
Jeddah 8
Karachi 8
Lấp Vò 8
Osasco 8
Panama City 8
Phủ Lý 8
San José 8
Shanghai 8
Tokyo 8
Warsaw 8
Asunción 7
Casablanca 7
Chennai 7
Erbil 7
Franca 7
Goiânia 7
Moscow 7
Natal 7
Ninh Bình 7
Totale 5.148
Salva come PNG Salva come JPEG
Nome #
A State-of-the-Art Review of Ophthalmological Indications for a Cesarean Section: Is There a Patient for Whom a Cesarean Section Is Really Indicated? 131
The Accuracy of Third-Trimester Ultrasound in Predicting Large for Gestational Age or Macrosomic Fetuses in Diabetic and Non-Diabetic Pregnant Women: A Systematic Review and Meta-Analysis 102
A NEW ULTRASOUND CRITERIUM FOR THE DIAGNOSIS OF POLYCYSTIC OVARY SYNDROME: PREDICTIVITY OF THE STROMA/AREA RATIO 96
A WHO 2021-based comprehensive scheme outlining sperm parameters’ associations with IVF outcomes in PGT-A cycles 95
Assessment of insulin resistance in lean women with polycystic ovary syndrome 95
Drospirenone for the treatment of hirsute women with polycystic ovary syndrome: A clinical, endocrinological, metabolic pilot study 93
AGEs-related dysfunctions in PCOS: evidence from animal and clinical research 89
Clinical efficacy andmetabolic impact of two different dosages of ethinyl-estradiol in association with drospirenone in normal-weight women with polycystic ovary syndrome: A randomized study 86
Selective effects of pioglitazone on insulin and androgen abnormalities in normo- and hyperinsulinaemic obese patients with polycystic ovary syndrome 85
A first stage placental site trophoblastic tumor: a case report and review of literature 84
COVID-19 and ART: the view of the Italian Society of Fertility and Sterility and Reproductive Medicine 84
Value of PGT-A when only one or two blastocysts are obtained: propensity-score matching and cost-effectiveness study 83
Pioglitazone reduces the adrenal androgen response to corticotropin-releasing factor without changes in ACTH release in hyperinsulinemic women with polycystic ovary syndrome 82
Position paper on prevention of surgical site infections in obstetric and gynecological surgery 82
Acute insulin response to intravenous glucagon in polycystic ovary syndrome 81
Administration of exogenous ghrelin in obese patients with polycystic ovary syndrome: effects on plasma levels of growth hormone, glucose, and insulin 81
Alterazioni funzionali: patogenesi, diagnosi e terapia delle cause ovariche 81
A pilot study of the long-term effects of acipimox in polycystic ovarian syndrome 80
Alterazioni della secrezione di GH nella sindrome dell'ovaio policistico: un nuovo fattore fisiopatologico 77
The resting metabolic rate in women with polycystic ovary syndrome and its relation to the hormonal milieu, insulin metabolism, and body fat distribution: a cohort study 76
Endocrinology: Differential androgen response to adrenocorticotrophin hormone stimulation and effect of opioid antagonist on insulin secretion in polycystic ovarian syndrome 75
Effects of ghrelin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome 75
Role of opioid antagonists in the treatment of women with glucoregulation abnormalities 74
Naltrexone effect on pulsatile GnRH therapy for ovulation induction in polycystic ovary syndrome: A pilot prospective study 72
Synchronous ovarian and uterine tumours: a case report of an unusual association 71
How to improve MRI accuracy in detecting deep infiltrating colorectal endometriosis: MRI findings vs. laparoscopy and histopathology 71
Factors associated with chronic pelvic pain in women with endometriosis: A national study on clinical and sociodemographic characteristics, lifestyles, quality of life, and perceptions of quality of care, during the COVID-19 pandemic 71
Clinical, obstetric and perinatal outcomes after vitrified-warmed euploid blastocyst transfer are independent of cryo-storage duration 70
Sex ratio at birth: causes of variation and narrative review of literature 70
Asymptomatic postmenopausal endometrial thickening: a comparison between transvaginal ultrasound and hysteroscopy in the diagnosis of intracavitary uterine pathologies 70
Alterazioni funzionali: patogenesi, diagnosi e terapia delle cause ovariche 69
Progesterone: The Key Factor of the Beginning of Life 69
Botulinum toxin in incontinent women with neurogenic bladder after failure with anticholinergic therapy, long-term results: a pilot study 69
Clinical efficacy and metabolic impact of two different dosages of ethinyl-estradiol with drospirenone in normal weight women with polycystic ovary syndrome 68
Evaluation of ovarian and adrenal sources of androgens in women with polycystic ovary syndrome: Dexamethasone and GnRH-agonist administration 67
Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin as a trigger of ovulation in polycystic ovarian disease gonadotropin hyperstimulated cycles 67
Hypothalamic-pituitary-adrenal axis sensitivity to opioids in women with polycystic ovary syndrome 67
INSULIN RESISTANCE AND WOMEN'S HEALTH 66
Human spermatogenesis in vitro: Respective effects of follicle- stimulating hormone and testosterone on meiosis, spermiogenesis, and sertoli cell apoptosis 66
Differences in AMH levels in the four polycystic ovary syndrome phenotypes based on Rotterdam criteria 66
EFFECT OF THE INSULIN-SENSITIZING DRUG METFORMIN ON THE GROWTH HORMONE RESPONSE TP GROWTH HORMONE RELEASING HORMONE IN OBESE WOMEN WITH POLYCYSTIC OVARY SYNDROME: RELATIONSHIP WITH FOOD INGESTION 66
Evidence of a disturbance of the hypothalamic-pituitary-adrenal axis in polycystic ovary syndrome: Effect of naloxone 65
Involvement of ovarian steroids in the opioid-mediated reduction of insulin secretion in hyperinsulinemic patients with polycystic ovary syndrome 65
Differentiation of spermatogenic cells during in-vitro culture of testicular biopsy samples from patients with obstructive azoospermia: Effect of recombinant follicle stimulating hormone 64
ADOLESCENTE CON ENDOMETRIOSI E PROSPETTIVE RIPRODUTTIVE. 63
INSULIN SECRETION IN POLYCYSTIC OVARY DISEASE (PCOD): A MULTIFACTORIAL PROBLEM 63
The metabolic status modulates the effect of metformin on the antimullerian hormone-androgens-insulin interplay in obese women with polycystic ovary syndrome 62
EFFECT OF PIOGLITAZONE TREATMENT ON THE ADRENAL ANDROGEN REPONSE TO CORTICOTROPHIN IN OBESE PATIENTS WITH POLYCYSTIC OVARY SYNDROME 62
DETRIMENTAL EFFECT OF AGE ON THE OVARIAN RESPONSE TO GONADOTROPIN AND ON PREGNANCY RATE IN POLYCYSTIC OVARIAN SYNDROME WOMEN 62
Alterazioni della secrezione di GH nella sindrome dell'ovaio policistico: un nuovo fattore fisiopatologico 61
Vaginal mesh exposure after laparoscopic sacrocervicopexy performed with permanent or absorbable sutures 61
ADOLESCENTE CON ENDOMETRIOSI E PROSPETTIVE RIPRODUTTIVE 60
Differential androgen response to adrenocorticotropic hormone stimulation in polycystic ovarian syndrome: Relationship with insulin secretion 60
The Role of Anti-Müllerian Hormone in the Characterization of the Different Polycystic Ovary Syndrome Phenotypes 59
INFLUENCE OF BODY MASS ON THE HYPOTHALAMIC-PITUITARY-ADRENAL-AXIS RESPONSE TO NALOXONE IN PATIENTS WITH POLYCYSTIC SYNDROME 59
VAGINAL MESH REPAIR SYSTEMS FOR PELVIC ORGAN PROLAPSE: ANATOMICAL STUDY COMPARING OUTSIDE-IN VS INSIDE-OUT-TECHNIQUES 59
INFLUENCE OF BODY MASS ON THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS RESPONSE TO NALAXONE IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME 59
GH RESPONSE TO FOOD INTAKE IN OBESE pcos WOMEN: EFFECT OF METFORMIN 59
Laparoscopic sacrocolpopexy versus pelvic organ prolapse suspension for surgical management of pelvic organ prolapse: a retrospective study 58
Changes in luteinizing hormone and insulin secretion in polycystic ovarian syndrome 57
L'INDUZIONE DELL'OVULAZIONE CON FSH PURIFICATO IN PAZIENTI AFFETTE DA SINDROME DELL'OVAIO POLICISTICO: POSSIBILI VANTAGGI DELLA TERAPIA A BASSE DOSI 57
ENDOSCOPIC SURGERY IN OVARIAN ENDOMETRIOSIS: HISTOPATOLOGIC OBSERVATIONS ON THE LOSS OF FOLLICULAR TISSUE DURING TREATMENT 57
IS THERE A ROLE FOR ISOLAVONES IN THE THERAPEUTIC APPROCH TO POLYCYSTIC OVARY SYNDROME? RESULTS FROM A PILOT STUDY 57
RECOMBINANT versus URINARY FOLLICLE STIMULATING HORMONE (FSH) IN THE LOW-DOSE REGIMEN IN ANOVULATORY PATIENTS WITH POLICYSTYC OVARY SYNDROME (PCOS): A SAFER AND MORE EFFECTIVE TREATMENT 57
Conservative management of preterm premature rupture of membranes < 30 weeks of gestational age: Effectiveness of clinical guidelines implementation strategies 57
Investigating Unhealthy Behaviors Associated with SF-36 Domains in Women with Endometriosis—Findings from a Web-Based Survey Data Set 57
Follicular loss in endoscopic surgery for ovarian endometriosis: quantitative and qualitative observations. 56
Metformin Effects tin Ovarian Ultrasound Appearance and Steroidogenic Function in Normal Weight, Normoinsulinemic Women with Polycystic Ovary Syndrome: A Randomized, Double Blind, Placebo-Controlled Clinical Trial 56
Sonographic features of pelvic tuberculosis mimicking ovarian-tubal-peritoneal carcinoma 56
Preconceptional and gestational evaluation of insulin secretion in patients with polycystic ovary syndrome 56
Nerve-Sparing Laparoscopic Colposacropexy Using a Percutaneous Surgical System: A Case Report 56
Using a 16-French Resectoscope as an Alternative Device in the Treatment of Uterine Lesions: A Randomized Controlled Trial 55
Perinatal mental illness and autoimmune diseases: a qualitative sistematic review 55
The link between metabolic features and TSH levels in polycystic ovary syndrome is modulated by the body weight: an euglycaemic-hyperinsulinaemic clamp study 55
ALTERATION OF GHRELIN-NEUROPEPTIDE Y NETWORK IN OBESE PATIENTS WITH POLYCYSTIC OVARY SYNDROME: ROLE OF HYPERINSULINISM 55
Metformin effects on ovarian ultrasound appearance and steroidogenic function in normal-weight normoinsulinemic women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial. 55
PIOGLITAZONE ADMINISTRATION IN HYPERINSULINEMIC WOMEN WITH PCOS DECREASES THE ADRENAL ANDROGEN RESPONSE TO CORTICOTROPHIN-RELEASING FACTOR 54
The Italian guidelines on non-invasive and invasive prenatal diagnosis: Executive summary of recommendations for practice the Italian Society for Obstetrics and Gynecology (SIGO) 54
TOPICAL HAEMOSTATICS AND SEALANTS IN GYNAECOLOGICAL AND OBSTETRIC 3 SURGERY: STATE OF THE ART 54
Is the PCOS diagnosis solved by ESHRE/ASRM 2003 consensus or could it include ultrasound examination of the ovarian stroma? 54
Influence of body mass on the hypothalamic-pituitary-adrenal-axis response to naloxone in patients with polycystic ovary syndrome 53
METFORMIN TREATMENT DOSE NOT AFFECT TOTAL LEPTIN LEVELS AND FREE LEPTIN INDEX IN OBESE PATIENTS WITH POLYCYSTIC OVARY SYNDROME 53
Conservative Management and Ultrasound Follow-Up of Parasitic Myoma: Our Experience and Literature Review 53
Low AMH levels as a marker of reduced ovarian reserve in young women affected by Down syndrome 53
Endocrinology: Effect of opioid blockade on insulin metabolism in polycystic ovarian disease 52
How should the best human embryo in vitro be? Current and future challenges for embryo selection 52
Favorable conception and pregnancy involving a male patient affected by chronic myeloid leukemia while taking dasatinib 52
CONTRACCEZIONE ORMONALE E SINDROME DELL'OVAIO POLICISTICO 51
Longitudinal metabolic observation of metformin effects during pregnancy in hyperinsulinemic women with polycystic ovary syndrome: A case report 51
Role of opioid tone in the pathophysiology of hyperinsulinemia and insulin resistance in polycystic ovarian disease 51
The Impact of Metal Nanoparticles on Female Reproductive System: Risks and Opportunities 51
Posterior mesh fixation versus non-fixation in sacrocolpopexy: A randomized clinical trial 51
Metaphase‑II oocyte competence is unlinked to the gonadotrophins used for ovarian stimulation: a matched case–control study in women of advanced maternal age 50
OPIOIDS AND GROWTH HORMONE IN POLYCYSTIC OVARY SYNDROME. EFFECT OF FEEDING. 50
GLI IPERANDROGENISMI E LA SINDROME DELL'OVAIO POLICISTICO 50
Recurrent Metastatic Pulmonary Synovial Sarcoma during Pregnancy: A Case Report and Literature Review 50
How metformin acts in PCOS pregnant women: insights into insulin secretion and peripheral action at each trimester of gestation 50
ROLE OF GnRH ANALOG PITUITARY DESENSITIZATION IN INDUCTION OF OVULATION IN POLYCYSTIC OVARIAN SYNDROME 50
The use of different size-hysteroscope in office hysteroscopy: our experience 50
Letter to the Editor - DTC chemotherapy regimen is associated with higher incidence of premature ovarian failure in women of reproductive age with breast cancer 50
Totale 6.516
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.217
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.217
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20231 0 0 0 0 0 0 1 0 0 0 0 0
2023/20243 0 0 0 0 0 1 0 0 1 0 0 1
2024/20251.724 0 2 1 0 215 197 103 73 302 113 140 578
2025/20267.450 1.034 379 303 770 1.347 508 791 340 417 543 473 545
2026/2027490 420 70 0 0 0 0 0 0 0 0 0 0
Totale 9.668